53 related articles for article (PubMed ID: 32558212)
1. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells.
Liu X; Xiong F; Wei X; Yang H; Zhou R
Cancer Sci; 2009 Dec; 100(12):2335-40. PubMed ID: 19843073
[TBL] [Abstract][Full Text] [Related]
2. Deletion of liver kinase B1 in POMC neurons predisposes to diet-induced obesity.
Wu Z; Han J; Xue J; Xi P; Wang H; He L; Wang Q; Liang H; Sun X; Tian D
Life Sci; 2020 Oct; 258():118204. PubMed ID: 32763296
[TBL] [Abstract][Full Text] [Related]
3. Retraction Note: The role of fibroblast activation protein in progression and development of osteosarcoma cells.
Zhang L; Yang L; Xia ZW; Yang SC; Li WH; Liu B; Yu ZQ; Gong PF; Yang YL; Sun WZ; Mo J; Li GS; Wang TY; Wang K
Clin Exp Med; 2023 Dec; 23(8):5481. PubMed ID: 37847470
[No Abstract] [Full Text] [Related]
4. miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma.
Yan R; Liu D; Wang J; Liu M; Guo H; Bai J; Yang S; Chang J; Yao Z; Yang Z; Blom T; Zhou K
Oncogenesis; 2023 May; 12(1):25. PubMed ID: 37147294
[TBL] [Abstract][Full Text] [Related]
5. High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification.
Jiang X; Tang F; Zhang J; He M; Xie T; Tang H; Liu J; Luo K; Lu S; Liu Y; Lu J; He M; Wei Q
Front Oncol; 2023; 13():991483. PubMed ID: 36845726
[TBL] [Abstract][Full Text] [Related]
6. KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment.
Han Y; Chen J; Wei D; Wang B
Comput Math Methods Med; 2022; 2022():6426800. PubMed ID: 36017147
[TBL] [Abstract][Full Text] [Related]
7. LAPTM4B-35 protein as a potential therapeutic target in gastric cancer.
Zhang H; Tian B; Yu H; Yao H; Gao Z
Tumour Biol; 2014 Dec; 35(12):12737-42. PubMed ID: 25416438
[TBL] [Abstract][Full Text] [Related]
8. Identification of Lysosome-Associated Protein Transmembrane-4 as a Novel Therapeutic Target for Osteosarcoma Treatment.
Wang ZX; Guo MY; Ren J; Li GS; Sun XG
Orthop Surg; 2020 Aug; 12(4):1253-1260. PubMed ID: 32558212
[TBL] [Abstract][Full Text] [Related]
9. Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma.
Wang ZX; Ren SC; Chang ZS; Ren J
Biomed Res Int; 2020; 2020():7102757. PubMed ID: 33204709
[TBL] [Abstract][Full Text] [Related]
10. The role of fibroblast activation protein in progression and development of osteosarcoma cells.
Zhang L; Yang L; Xia ZW; Yang SC; Li WH; Liu B; Yu ZQ; Gong PF; Yang YL; Sun WZ; Mo J; Li GS; Wang TY; Wang K
Clin Exp Med; 2020 Feb; 20(1):121-130. PubMed ID: 31745677
[TBL] [Abstract][Full Text] [Related]
11. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro.
Meng F; Chen X; Song H; Lou G
Cell Physiol Biochem; 2015; 37(3):890-900. PubMed ID: 26383850
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
